Skip to main content
. 2025 Dec 19;6(3):314–325. doi: 10.1016/j.jacasi.2025.09.027

Table 1.

Patient Characteristics Stratified by Strata

All (N = 1,935) Endogenous
Cardiac Stratum (n = 1,417)
Endogenous
Noncardiac Stratum (n = 305)
Exogenous
Stratum (n = 213)
P Value
Age, y 58.9 ± 14.0 58.8 ± 13.4 58.8 ± 14.3 59.5 ± 16.9 0.72
 Age ≥75 ya 239 (12.4) 154 (10.9) 41 (13.4) 44 (20.7) <0.001
Male 1,597 (82.5) 1,229 (86.7) 215 (70.5) 153 (71.8) <0.001
Body mass index, kg/m2 24.7 ± 4.4 24.8 ± 4.2 24.8 ± 5.2 23.9 ± 5.0 0.10
Comorbidity
 Hypertensionb 755 (29.8) 453 (32.0) 78 (25.6) 46 (21.6) 0.002
 Diabetes mellitus 367 (19.0) 307 (21.7) 27 (8.9) 33 (15.5) <0.001
 Dyslipidemia 204 (10.5) 180 (12.7) 14 (4.6) 10 (4.7) <0.001
 Cardiovascular diseaseb 443 (22.9) 384 (27.1) 31 (10.2) 28 (13.2) <0.001
 Cerebrovascular diseaseb 123 (6.4) 92 (6.5) 16 (5.3) 15 (7.0) 0.66
 Chronic renal failureb 93 (4.8) 77 (5.4) 10 (3.3) 6 (2.8) 0.10
Medication
 Antiplatelet 212 (11.0) 184 (13.0) 16 (5.3) 12 (5.6) <0.001
 Anticoagulant 101 (5.2) 80 (5.7) 10 (3.3) 11 (5.2) 0.24
 Antiplatelet or anticoagulanta 245 (12.7) 208 (14.7) 20 (6.6) 17 (8.0) <0.001
 Antiplatelet and anticoagulant 34 (1.8) 28 (2.0) 3 (1.0) 3 (1.4) 0.45
 No antiplatelet and anticoagulant 1,656 (85.6) 1,181 (83.4) 282 (92.5) 193 (85.6) <0.001
Location of cardiac arrest <0.001
 Home 785 (40.7) 551 (39.0) 143 (47.0) 91 (42.9)
 Workplace 206 (10.7) 163 (11.5) 27 (8.9) 16 (7.6)
 Public place 328 (17.0) 271 (19.2) 37 (12.2) 20 (9.4)
 Street 254 (13.2) 204 (14.4) 24 (7.9) 26 (12.3)
 Witnessed by EMS 230 (11.9) 142 (10.0) 61 (20.1) 27 (12.7)
 Others 126 (6.5) 82 (5.8) 12 (4.0) 32 (15.1)
Witnessed cardiac arrest 1,474 (76.6) 1,101 (78.1) 242 (79.6) 131 (62.4) <0.001
Bystander CPRb 1,074 (56.6) 791 (56.7) 191 (64.3) 92 (44.9) <0.001
Initial cardiac rhythm <0.001
 VF 1190 (62.1) 1010 (71.8) 75 (24.8) 105 (50.7)
 VT 37 (1.9) 28 (2.0) 4 (1.3) 5 (2.4)
 PEA 501 (26.2) 265 (18.9) 180 (59.4) 56 (27.1)
 Asystole 188 (9.8) 103 (7.3) 44 (14.5) 41 (19.8)
Albumin, mg/dL 3.1 ± 0.7 3.1 ± 0.7 2.9 ± 0.8 3.1 ± 0.8 <0.001
 Albumin <4 mg/dLb 1,586 (89.5) 1,177 (89.3) 248 (92.5) 161 (86.6) 0.11
eGFR, mL/min/1.73 m2 52.0 ± 21.9 51.4 ± 18.7 51.4 ± 27.4 57.4 ± 30.6 0.042
 eGFR <60 mL/min/1.73 m2a 1,331 (71.2) 1,003 (72.9) 199 (69.6) 129 (62.3) 0.006
CRP, mg/dL 1.0 ± 3.2 0.7 ± 0.1 2.1 ± 0.2 1.6 ± 0.2 <0.001
 CRP 5 mg/dLa 83 (4.6) 39 (2.9) 28 (10.1) 16 (8.0) <0.001
White blood cells/μL 10,176 ± 4,738 10,506 ± 4,660 9,790 ± 4,816 8,535 ± 4,782 <0.001
Hemoglobin, g/dL 12.5 ± 2.9 12.8 ± 2.6 11.5 ± 3.2 11.7 ± 3.3 <0.001
 Hemoglobin <11 g/dLa 501 (26.8) 308 (22.5) 119 (41.3) 74 (35.6) <0.001
Platelet ×104/μL 15.3 ± 7.4 15.5 ± 7.1 14.4 ± 7.6 15.1 ± 9.8 0.015
 Platelet <10 × 104/μLa 403 (21.6) 267 (19.5) 80 (27.8) 56 (27.1) 0.001
Fibrinogen, mg/dL 226.6 ± 107.0 228.4 ± 94.4 213.4 ± 138.1 233.5 ± 128.9 <0.001
 Fibrinogen <200 mg/dLb 705 (41.7) 488 (39.8) 139 (51.5) 78 (39.8) 0.002
APTT, s 46.0 (34.4-84.6) 45.0 (33.9-83.2) 53.5 (38.6-90.2) 45.7 (35.0-93.0) 0.008
 APTT ≥60 sb 652 (36.8) 457 (35.2) 123 (44.9) 72 (36.6) 0.010
D-dimer, μg/mL 13.2 (5.2-30.8) 12.3 (5.0-28.2) 23.8 (9.6-68.4) 8.9 (2.8-27.1) <0.001
 D-dimer ≥5 μg/mLa 1,282 (75.6) 925 (75.2) 241 (86.7) 116 (61.7) <0.001
Lactate, mmol/L 12.9 ± 4.3 13.1 ± 4.1 12.8 ± 4.4 11.4 ± 5.2 <0.001
 Lactate >5 mmol/La 1,634 (95.7) 1,235 (97.2) 239 (95.2) 160 (86.5) <0.001
ECMO cannulation place <0.001
 Emergency room 1,250 (65.1) 887 (63.0) 194 (64.2) 169 (79.7)
 Catheter laboratorya 668 (34.8) 517 (36.7) 108 (35.8) 43 (20.3)
 Others 3 (0.2) 3 (0.2) 0 (0.0) 0 (0.0)
Institutiona
 Q1 1,074 (55.5) 750 (52.9) 197 (64.6) 127 (59.6) <0.001
 Q2 484 (25.0) 369 (26.0) 67 (22.0) 48 (22.5) 0.22
 Q3 259 (13.4) 197 (13.9) 29 (9.5) 33 (15.5) 0.078
 Q4 118 (6.1) 101 (7.1) 12 (3.9) 5 (2.4) 0.006
Coronary angiography 1,364 (70.5) 1,180 (83.3) 119 (39.0) 65 (30.5) <0.001
Percutaneous catheter intervention 766 (40.8) 745 (54.0) 13 (4.5) 8 (3.9) <0.001
IABP insertiona 1,099 (56.9) 1,000 (70.7) 60 (19.9) 39 (18.3) <0.001
Temporary pacemaker 105 (5.8) 95 (7.2) 6 (2.1) 4 (2.0) <0.001
CRRT 241 (12.5) 199 (14.0) 22 (7.2) 20 (9.4) 0.002
Length of ICU stay, d 3 (1-10) 4 (1-11) 1 (1-5) 2 (1-5) <0.001
Length of hospital stay, d 3 (1-18) 4 (1-22) 2 (1-6) 2 (1-10) <0.001
Survival at hospital discharge 500 (25.8) 404 (28.5) 45 (14.8) 51 (23.9) <0.001

Values are mean ± SD or n (%).

APTT = activated partial thromboplastin time; CPR = cardiopulmonary resuscitation; CRP = C-reactive protein; CRRT = continuous renal replacement therapy; ECMO = extracorporeal membrane oxygenation; eGFR = estimated glomerular filtration rate; EMS = emergency medical service; IABP = intra-aortic balloon pumping; ICU = intensive care unit; PEA = pulseless electrical activity; VF = ventricular fibrillation; VT = ventricular tachycardia.

a

Covariables used in the multivariate analysis.

b

Covariates added in the sensitivity analysis.